JAK2 and myeloproliferative neoplasm: It is known that the JAK2-STAT3 pathway is involved in collagen-induced platelet activation [26], and it has been demonstrated that a constitutive Src kinase preactivation is involved in platelet hyperreactivity in patients with MPN [27].